Recurrent attacks of exertional rhabdomyolysis can develop from several enzyme defects of glyco(geno)lysis or lipid metabolism.I Rhabdomyolysis has not been associated with Ca2+ -adenosine triphosphatase (Ca2+-ATPase) deficiency. This rare disorder of muscle function was first described by Brody in 1969.2 In recent years three reports have been published, describing patients with deficiency of sarcoplasmic reticulum-ATPase.-5 Exercise-induced muscle contractures and impaired relaxation of exercising muscles belong to the main clinical symptoms. The deficiency causes a reduced uptake of Ca2+ in sarcoplasmic reticulum. Several studies have shown the importance of calcium ions in the contraction-relaxation cycle of striated muscles. 2 We describe a patient with exertional myalgia and recurrent rhabdomyolysis. We tested this patient with dantrolene sodium since this drug has been suggested to be useful in the treatment of exertional myalgia and recurrent rhabdomyolysis." Dantrolene sodium acts primarily by decreasing the sarcoplasmic reticulum calcium release and depresses the trigger mechanism for the excitationcontraction coupling, which is supposed to play a key role in the development of muscle pain and stiffness.69 The effect of dantrolene sodium on muscle symptoms and on ischaemic exercise tests is discussed.
Case report A 38 year old male presented with exertional myalgia and postexercise muscle weakness. These symptoms of exercise-intolerance started during the first decade of life. His skeletal muscles became stiff and painful 5 minutes after the start of moderate isometric exercise. He had many episodes of pigmenturia, especially after sport. He was not able to play a volleyball match to the end because of stiffening of the exercised muscles. The muscle symptoms then lasted for at least 12 hours. He frequently experienced "cramping" in the calf muscles. Walking and cycling caused no problems. When chewing firmly, the masticatory muscles became stiff and the relaxation was impaired. The patient did not experience a second wind phenomenon. The family history was noncontributory. Physical examination revealed no abnormalities. There was no muscle atrophy and no muscle weakness. Grip and percussion myotonia were absent. Laboratory studies showed a continuously elevated serum CK ranging from 500 to 1500 IU/L (normal range The main difference between our patient and the previous cases2-5 is the exertional recurrent rhabdomyolysis, confirmed by elevated CK levels. For muscle relaxation to occur, Ca2+-ions released into cytosol during contraction, must be taken up into the sarcoplasmic reticulum lumen through activity of Ca2+-ATPase located in the sarcoplasmic reticulum membrane. The partial deficiency of this enzyme may explain the main presenting symptoms in this disease: problems in relaxation of muscles, aggravated by exercise, muscle stiffness and exertional myalgia. When sarcoplasmic reticulum Ca2+-uptake cannot keep pace with Ca2+-release, then an accumulation of Ca2+ in muscle cytosol will occur. If at a critical level, a sustained elevation in cytosolic Ca2+-concentration will be damaging to muscle cells, and will result in muscle cell necrosis and pigmenturia. Myoglobinuria has not yet been associated with Ca2+-ATPase deficiency, which may be attributed to the very small number of case reports up till now. The degree of deficiency of Ca2+-ATPase may be important for the development of muscle damage. Verapamil and dantrolene sodium are the therapeutic drugs that have been successfully used in the treatment of exertional myalgia. In the patient described by Taylor dantrolene sodium reduced the pain, but produced unacceptable weakness.5 Verapamil proved to be effective. The therapeutic use of dantrolene sodium in preventing muscle necrosis has been reported before in animal experiments.6 Its beneficial effect in humans has also been reported by us and others in treating exertional myalgia and preventing recurrent attacks of rhabdomyolySiS.8 917 In our patient dantrolene sodium also had a positive effect upon exercise tolerance and muscle complaints; moreover, CK level and plasma potassium efflux from ischaemic exercising muscles became normal.
Recurrent rhabdomyolysis in metabolic myopathies is mainly precipitated by exercise. The number of recognised metabolic defects has increased in the past two decades, but in about half of the cases the biochemical cause of recurrent rhabdomyolysis remains unknown. ' We suggest that account Ca2+-ATPase deficiency as a metabolic cause of recurrent exertional rhabdomyolysis should be considered.
